Korsana Biosciences, Inc.（KRSA）價格預測KRSAKorsana Biosciences, Inc.

Korsana Biosciences (KRSA) appears to be a good buy right now due to its recent analyst upgrades and strong potential in the Alzheimer's treatment market. The stock is currently priced at $31.31, significantly below the analyst price targets of $70 and $44, indicating substantial upside potential. Furthermore, the gross margin stands at 100% for the upcoming quarters, reflecting the company's strong profitability potential once it begins generating revenue. However, the main risk is the projected net income loss of $3,177,000 in Q1 2026, which highlights ongoing financial challenges.

Korsana Biosciences, Inc. (KRSA) last closed at $30.2199993, gaining +0.37%. These facts feed the 1-day and 1-week KRSA price prediction above.